PISANO, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 527
EU - Europa 308
AS - Asia 155
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 995
Nazione #
US - Stati Uniti d'America 519
IT - Italia 95
IE - Irlanda 80
CN - Cina 58
SE - Svezia 51
GB - Regno Unito 20
HK - Hong Kong 16
IN - India 16
IR - Iran 13
JP - Giappone 13
UA - Ucraina 11
ES - Italia 10
SG - Singapore 9
CH - Svizzera 7
KR - Corea 7
TR - Turchia 7
CA - Canada 6
PH - Filippine 6
PL - Polonia 6
NL - Olanda 5
BE - Belgio 4
CZ - Repubblica Ceca 4
DE - Germania 4
FR - Francia 4
FI - Finlandia 3
MY - Malesia 3
HU - Ungheria 2
MX - Messico 2
NG - Nigeria 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 995
Città #
Chandler 164
Dublin 80
Nyköping 37
Turin 33
Medford 17
Princeton 15
Hangzhou 14
Ashburn 13
Seattle 13
Torino 12
Genoa 9
London 9
Beijing 8
Tokyo 8
Fairfield 7
Moncalieri 7
New York 7
Hebei 6
Hong Kong 6
Los Angeles 6
Milan 6
Seoul 6
Wilmington 6
Hyderabad 5
Isfahan 5
Madrid 5
Singapore 5
Chengdu 4
Chennai 4
Montreal 4
Ankara 3
Boston 3
Chicago 3
Coventry 3
Dagupan 3
Guangzhou 3
Liverpool 3
Petaling Jaya 3
Redmond 3
San Diego 3
Vezia 3
Abuja 2
Ann Arbor 2
Barletta 2
Buffalo 2
Changsha 2
Croydon 2
Dalian 2
Davao City 2
Dearborn 2
Devrek 2
Dong Ket 2
Edmonton 2
Falls Church 2
Gdynia 2
Germantown 2
Ghent 2
Guadalajara 2
Guadix 2
Guiyang 2
Hawthorne 2
Hoover 2
Hradec Králové 2
Istanbul 2
Johnston 2
Kolkata 2
Krakow 2
Lappeenranta 2
Leipzig 2
Maastricht 2
Maniowy 2
Marseille 2
Nagytarcsa 2
New Delhi 2
Novate Milanese 2
San Marcos 2
Trento 2
Woodbridge 2
Wuhan 2
Zurich 2
Adelaide 1
Alessandria 1
Amsterdam 1
Anqing 1
Auckland 1
Austin 1
Bellinzona 1
Birmingham 1
Bonn 1
Brooklyn 1
Cambridge 1
Central 1
Central District 1
Chiang Rai 1
Cuneo 1
Falconara Marittima 1
Fremont 1
Fukuoka 1
General Trias 1
Gifu City 1
Totale 652
Nome #
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 199
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 76
Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves 61
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside 51
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC) 51
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 47
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center 47
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 44
Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game Rules 42
Immunotherapy in cervix cancer 39
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 39
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 38
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 37
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements 35
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 30
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 29
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 29
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 25
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center 24
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 17
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience 16
Totale 1.025
Categoria #
all - tutte 5.108
article - articoli 0
book - libri 0
conference - conferenze 215
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 1 0 0 1 0 1 1 1 1 1 1 1
2020/202120 0 0 0 0 1 0 2 3 4 2 3 5
2021/2022211 23 5 9 1 7 1 6 4 13 23 68 51
2022/2023577 37 76 16 36 41 112 41 48 70 29 39 32
2023/2024206 29 44 21 30 11 24 10 13 5 19 0 0
Totale 1.025